CONGENITAL HEART DISEASE |
|
Year : 2002 | Volume
: 3
| Issue : 2 | Page : 7 |
|
Congenital heart disease - C: Transcatheter closure of secundum atrial septal defects in children and adults
Assad Al Hroob
Pediatric Cardiology Section, Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha; Consultant Pediatric Cardiologist, Hamad Medical Corporation, Doha
Correspondence Address:
Assad Al Hroob Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, P.O. Box 3050, Doha
 Source of Support: None, Conflict of Interest: None  | Check |

|
|
Surgical treatment of atrial septal defect is well established. With the advances in transcatheter therapy, closure of septal defects in the catheterization laboratory has also been introduced using various types of devices. These devices have been subjected to extensive clinical trials to evaluate their safety and appropriateness in children and adult patients. This review outlines the current status of these devices especially the new generation of devices (Amplatzer, Cardio seal, Helix) and the current recommendations for closure of PFO/ASD in children and adults in variable clinical circumstances. |
|
|
|
[FULL TEXT] [PDF Not available]* |
|
 |
|